Sumitomo Mitsui Trust Amends Arcturus Therapeutics Stake

Ticker: ARCT · Form: SC 13G/A · Filed: Feb 5, 2024 · CIK: 1768224

Arcturus Therapeutics Holdings Inc. SC 13G/A Filing Summary
FieldDetail
CompanyArcturus Therapeutics Holdings Inc. (ARCT)
Form TypeSC 13G/A
Filed DateFeb 5, 2024
Risk Levellow
Pages5
Reading Time6 min
Key Dollar Amounts$0.001
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: institutional-ownership, amendment, equity-holdings

TL;DR

**Sumitomo Mitsui Trust updated their Arcturus Therapeutics holdings, confirming their continued stake.**

AI Summary

Sumitomo Mitsui Trust Holdings, Inc. (SMTH) filed an amended Schedule 13G/A on February 5, 2024, indicating their ownership of Arcturus Therapeutics Holdings Inc. common stock as of December 31, 2023. This amendment, their second, updates their previous disclosures regarding their stake in the pharmaceutical company. This matters to investors because it provides transparency into significant institutional holdings, which can influence stock stability and investor confidence in Arcturus Therapeutics.

Why It Matters

This filing shows that a major financial institution, Sumitomo Mitsui Trust Holdings, Inc., continues to hold a significant position in Arcturus Therapeutics, signaling their ongoing interest and confidence in the company.

Risk Assessment

Risk Level: low — This is a routine amendment filing by an institutional investor, indicating no immediate new risks or significant changes.

Analyst Insight

Investors should note the continued institutional ownership by Sumitomo Mitsui Trust Holdings, Inc. in Arcturus Therapeutics, which can be a positive signal of long-term confidence, but this filing alone doesn't suggest immediate buying or selling action.

Key Players & Entities

  • Sumitomo Mitsui Trust Holdings, Inc. (company) — the reporting person and institutional investor
  • Arcturus Therapeutics Holdings Inc. (company) — the subject company whose stock is being reported
  • NIKKO ASSET MANAGEMENT CO., LTD. (company) — a group member associated with the filing
  • December 31, 2023 (date) — the date of the event requiring the filing
  • February 5, 2024 (date) — the filing date of the SC 13G/A

FAQ

What type of filing is this document?

This document is an SC 13G/A, which is an amendment to a Schedule 13G filing under the Securities Exchange Act of 1934, specifically Amendment No. 2.

Who is the reporting person in this filing?

The reporting person is Sumitomo Mitsui Trust Holdings, Inc. (SMTH), with a business address at 1-1, Shibakoen, 1-chome, Minato-ku, Tokyo, Japan.

What is the subject company whose securities are being reported?

The subject company is Arcturus Therapeutics Holdings Inc., located at 10628 Science Center Drive, Suite 250, San Diego, CA 92121.

What is the CUSIP number for the securities reported?

The CUSIP number for the common stock of Arcturus Therapeutics Holdings Inc. is 03969T109.

What was the date of the event that required this filing?

The date of the event which required the filing of this statement was December 31, 2023.

Filing Stats: 1,419 words · 6 min read · ~5 pages · Grade level 7.3 · Accepted 2024-02-05 06:08:57

Key Financial Figures

  • $0.001 — me of Issuer) Common stock, par value $0.001 per share (Title of Class of Securiti

Filing Documents

(a). Name of Issuer

Item 1(a). Name of Issuer: Arcturus Therapeutics Holdings Inc.

(b). Address of Issuer's Principal Executive Offices

Item 1(b). Address of Issuer's Principal Executive Offices: 10628 Science Center Drive, Suite 250 San Diego, California 92121

(a). Name of Person Filing

Item 2(a). Name of Person Filing: Sumitomo Mitsui Trust Holdings, Inc. Nikko Asset Management Co., Ltd.

(b). Address of Principal Business Office or, if None, Residence

Item 2(b). Address of Principal Business Office or, if None, Residence: SMTH: 1-4-1 Marunouchi, Chiyoda-ku, Tokyo 100-8233, Japan NAM: Midtown Tower, 9-7-1 Akasaka, Minato-ku, Tokyo 107-6242, Japan

(c). Citizenship

Item 2(c). Citizenship: SMTH: Japan NAM: Japan

(d). Title of Class of Securities

Item 2(d). Title of Class of Securities: Common stock, par value $0.001 per share

(e). CUSIP Number

Item 2(e). CUSIP Number: 03969T109 Page 4 of 9

If this Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b)

Item 3. If this Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: SMTH: (a) o Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o); (b) o Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) o Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) o Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) o An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); (f) o An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); (g) x A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); (h) o A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) o A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) x A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J); (k) o Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: Parent Holding Company NAM: (a) o Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o); (b) o Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) o Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) o Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) x An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); (f) o An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); (g) x A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); (h) o

Ownership

Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of issuer identified in Item 1. SMTH: (a) Amount beneficially owned: 1,320,652 (b) Percent of class: 4.94% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 1,320,652 (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 1,320,652 NAM: (a) Amount beneficially owned: 1,320,652 (b) Percent of class: 4.94% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 1,320,652 (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 1,320,652 Page 6 of 9

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following. x

Ownership of More than Five Percent on Behalf of Another Person

Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable.

Identification and Classification of the Subsidiary Which Acquired

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. See Exhibit A.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group. Not applicable.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group. Not applicable.

Certifications

Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Page 7 of 9 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 5, 2024 Sumitomo Mitsui Trust Holdings, Inc. (Company) /s/ Hideaki Takamiya (Signature) Hideaki Takamiya / Senior Manager of Risk Management Dept (Name/Title) Nikko Asset Management Co.,Ltd (Company) /s/ Atsushi Ohya (Signature) Atsushi Ohya / Head of Business Regulatory Compliance (Name/Title) Page 8 of 9 Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the securities being reported on by each of SMTH and NAM, as parent holding companies, are owned, or may be deemed to be beneficially owned, by their subsidiary Nikko Asset Management Americas, Inc., which is classified as an investment adviser in accordance with §240.13d-1(b)(1)(ii)(E). Page 9 of 9

View Full Filing

View this SC 13G/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.